<unk>  refers to a regimen consisting of fludarabine, mitoxantrone, cyclophosphamide and rituximab,  used in the treatment of resistant or relapsed chronic lymphocytic leukaemia.
FMC-R regimen
ICE-R regimen
RCD regimen
COPP regimen
FN-D regimen
MINE-R regimen
FMR regimen
DICE regimen